Similarly, CRISPR/CAS9-mediated reconstitution of UCP1 in WAT of pigs led to significantly decreased fat mass and improved energy expenditure (12), suggesting the therapeutic potential of modulating WAT phenotype by activation of key thermogenic genes for fighting obesity and metabolic syndrome. Here, UCP1 is linked to obesity due to melanocortin 4 receptor deficiency.